A Novel Mutation in an MNGIE Patient Presenting with More Prominent Neurological Symptoms than GI Symptoms

Neurol India. 2023 Mar-Apr;71(2):323-325. doi: 10.4103/0028-3886.375429.

Abstract

Mitochondrial neurogastrointestinal encephalopathy (MNGIE) is an autosomal recessive disease associated with the mutation of the TYMP gene. MNGIE causes gastrointestinal and neurological symptoms, and the gastrointestinal symptoms are usually notable, which may lead to misdiagnosis. However, we herein report a 29-year-old female who presented with prominent neurological symptoms, while her gastrointestinal symptoms were mild. Brain MRI revealed prominent diffused leukoencephalopathy and peripheral neuropathy was confirmed by the nerve conduction velocity test. Biochemical tests showed elevated plasma thymidine, deoxyuridine, and lactate levels. Molecular genetic testing demonstrated a novel homozygous TYMP c. 447 dupG mutation and the patient's mother was heterozygous for the mutation but had no clinical features. MNGIE was diagnosed based on the results. Unlike other patients who had notable gastrointestinal symptoms, this patient presented with more prominent neurological symptoms than gastrointestinal symptoms, which might have been caused by the novel mutation in the TYMP gene.

Keywords: Frameshift mutation; MNGIE; TYMP; neurological symptoms; novel mutation.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Female
  • Genetic Testing
  • Humans
  • Mitochondrial Encephalomyopathies* / complications
  • Mitochondrial Encephalomyopathies* / diagnosis
  • Mitochondrial Encephalomyopathies* / genetics
  • Mutation / genetics
  • Thymidine Phosphorylase / genetics

Substances

  • Thymidine Phosphorylase

Supplementary concepts

  • Visceral myopathy familial external ophthalmoplegia